Health
Mel Gibson Drops Two Medical Bombshells on the Joe Rogan Podcast

From The Vigilant Fox
Being familiar with alternative cancer therapies, Rogan concluded Gibson was talking about antiparasitic drugs Ivermectin and Fenbendazole, which Gibson confirmed with a nod.
In the final hour of episode #2254 of The Joe Rogan Experience, actor Mel Gibson shared two shocking medical experiences that defy mainstream knowledge.
It all started the moment Anthony Fauci’s name lept out of Gibson’s mouth.
“I don’t know why Fauci’s still walking around… or at least free,” Gibson remarked before revealing that he had “road rage” after listening to RFK Jr.’s book about Anthony Fauci.
Piling on, Joe Rogan quickly dismantled any doubts about the book’s accuracy, arguing that if it were full of lies, RFK Jr. would have been sued into the ground and publicly humiliated.
“First of all, people that don’t believe it. How come RFK Jr. didn’t get sued? How come there’s no lawsuits? If there were lies, there would be lawsuits. You’d be publicly humiliated,” Rogan pointed out.
“That book is an accurate depiction of what Anthony Fauci did during the AIDS crisis, which probably was an AZT crisis. It wasn’t an AIDS crisis.”
The first bombshell dropped when Gibson shared that he “couldn’t walk for three months” after taking Fauci’s pet drug for COVID.
“[Remdesivir] kills you. I found out that afterward. And that’s why I wonder about Fauci,” Gibson said.
“Remdesivir is so lethal it got nicknamed ‘Run Death Is Near’ after it started killing thousands of COVID patients in the hospital,” Stella Paul wrote in a previous report.
“The experts claimed that remdesivir would stop COVID; instead, it stopped kidney function, then blasted the liver and other organs.”
Unfortunately, Gibson’s gardener wasn’t as fortunate. After reportedly receiving the kidney-toxic treatment, he tragically passed away.
“I knew the guy for 20 years, and we both went to the same hospital, and he died, and I didn’t,” Gibson lamented. “I think we both got remdesivir, which is not good.”
While you’re here, please take a few seconds to subscribe for more
reports like this one.
The most jaw-dropping moment happened when Gibson made a statement that could threaten the entire cancer industry.
Gibson revealed that he has three friends who had “stage four cancer,” and now “all three of them don’t have cancer right now at all.”
“And they had some serious stuff going on,” Gibson added.
Rogan asked, “What did they take?”—to which Gibson hesitantly replied, “They took what you’ve heard they’ve taken.”
Being familiar with alternative cancer therapies, Rogan concluded Gibson was talking about antiparasitic drugs Ivermectin and Fenbendazole, which Gibson confirmed with a nod.
Corroborating what Gibson reported to Rogan, cancer surgeon Dr. Kathleen Ruddy revealed to The Epoch Times last year that she has seen several late-stage cancer patients make dramatic recoveries after taking Ivermectin.
One patient had a grim future, and then something remarkable happened. This man had stage four prostate cancer and tried all the conventional protocols before doctors told him that there was nothing they could do.
Then, he started taking ivermectin…
Within six months, the metastatic lesions began to disappear, and in less than a year, “he was out dancing for four hours” three nights per week, according to Dr. Ruddy.
A similar scenario unfolded for another man named Eddie. He was also in bad shape.
Eddie was diagnosed with two unresectable esophageal tumors that surgeons wouldn’t go near. He was a smoker, couldn’t swallow, and had lost 40 pounds in a year and a half.
“Within a couple of weeks, he sounded stronger. He could swallow. He had gained six pounds. His voice was better,” reported Dr. Ruddy.
Several weeks later, Dr. Ruddy said to Eddie, “You need to get a scan.”
Guess what happened?
“We got the scan. No tumors. Gone. Gone. The problem was that he had sold his fishing boat. That was the biggest problem. He was getting better. His tumor was gone. Now he’s got to buy another fishing boat … I was like, ‘Well, now, that’s interesting.’”
Recently, anecdotal reports have also praised Fenbendazole as a potentially miraculous anti-cancer drug.
It reportedly works by destabilizing microtubules, the structures that help cancer cells divide and grow.
By disrupting this process, Fenbendazole is believed to effectively halt cancer cell division and slow or stop tumor growth.
A case series published in 2020 documented three cancer patients who experienced complete remission after taking Fenbendazole.
“FBZ (Fenbendazole) appears to be a potentially safe and effective antineoplastic agent that can be repurposed for human use in treating genitourinary malignancies.’”
Adding to the growing evidence in support of Fendendazole’s use case against cancer, an Oklahoma man credited his miraculous cancer recovery to the pet med after overcoming terminal small cell lung cancer, defying a less than 1% survival rate and leaving doctors baffled.
EDMOND, Okla. — When you tell someone a medicine for dogs cured your cancer, you better be ready for some skeptics, but Joe Tippens says it saved his life, and the lives of others.
Now, even cancer researchers are open to the possibility it might be true.
“My stomach, my neck, my liver, my pancreas, my bladder, my bones — it was everywhere,” Tippens said.
Tippens said he was told to go home, call hospice and say his goodbyes two years ago.
The doctors were unanimous, he was going to die of small cell lung cancer.
“Once that kind of cancer goes that far afield, the odds of survival are less than 1 percent, and median life expectancy is three months,” Tippens said.
Tippens said he went from 220 pounds to 110.
“I was a skeleton with skin hanging off of it,” he said. “It was difficult.”
But that was January of 2017. Today, Tippens is very much alive and what he credits for his survival has doctors scratching their heads, and the rest of us raising eyebrows.
“About half the people think I’m just crazy,” he said. “And about half the people want to know more and dig deeper.”
Tippens said he received a tip from a veterinarian, of all people. And in his desperation, he turned from people medicine to dog medicine.
Specifically, something you give your dog when it has worms.
“The truth is stranger than fiction, you know?” Tippens said, laughing.
Just three months later, Tippens says, his cancer was gone.
Thanks for reading! If you enjoyed this post, please do me a quick favor and follow this page (@VigilantFox) for more reports like this one.
2025 Federal Election
MEI-Ipsos poll: 56 per cent of Canadians support increasing access to non-governmental healthcare providers

-
Most believe private providers can deliver services faster than government-run hospitals
-
77 per cent of Canadians say their provincial healthcare system is too bureaucratic
Canadians are increasingly in favour of breaking the government monopoly over health care by opening the door to independent providers and cross-border treatments, an MEI-Ipsos poll has revealed.
“Canadians from coast to coast are signalling they want to see more involvement from independent health providers in our health system,” explains Emmanuelle B. Faubert, economist at the MEI. “They understand that universal access doesn’t mean government-run, and that consistent failures to deliver timely care in government hospitals are a feature of the current system.”
Support for independent health care is on the rise, with 56 per cent of respondents in favour of allowing patients to access services provided by independent health entrepreneurs. Only 25 per cent oppose this.
In Quebec, support is especially strong, with 68 per cent endorsing this change.
Favourable views of accessing care through a mixed system are widespread, with three quarters of respondents stating that private entrepreneurs can deliver healthcare services faster than hospitals managed by the government. This is up four percentage points from last year.
Countries like Sweden and France combine universal coverage with independent providers and deliver faster, more accessible care. When informed about how these health systems run, nearly two in three Canadians favour adopting such models.
The poll also finds that 73 per cent of Canadians support allowing patients to receive treatment abroad with provincial coverage, which could help reduce long wait times at home.
Common in the European Union, this “cross-border directive” enabled 450,000 patients to access elective surgeries in 2022, with costs reimbursed as if they had been treated in their home country.
There’s a growing consensus that provincial healthcare systems are overly bureaucratic, with the strongest agreement in Alberta, B.C., and Quebec. The proportion of Canadians holding this view has risen by 16 percentage points since 2020.
Nor do Canadians see more spending as being a solution: over half say the current pace of healthcare spending in their province is unsustainable.
“Governments shouldn’t keep doubling down on what isn’t working. Instead, they should look at what works abroad,” says Ms. Faubert. “Canadians have made it clear they want to shift gears; now it’s up to policymakers to show they’re listening.”
A sample of 1,164 Canadians aged 18 and older was polled between March 24th and March 28th, 2025. The margin of error is ±3.3 percentage points, 19 times out of 20.
The results of the MEI-Ipsos poll are available here.
* * *
The MEI is an independent public policy think tank with offices in Montreal, Ottawa, and Calgary. Through its publications, media appearances, and advisory services to policymakers, the MEI stimulates public policy debate and reforms based on sound economics and entrepreneurship.
Health
Trump admin directs NIH to study ‘regret and detransition’ after chemical, surgical gender transitioning

From LifeSiteNews
Ample evidence has surfaced in recent years to warrant the White House’s investigation
The Trump administration has made a break with the long-standing government policy of near 100% affirmation of the transgender industry’s efforts and has directed the National Institutes of Health (NIH) to study the negative impacts on mental and physical health of so-called “gender transitioning” on adults and children.
The Department of Health and Human Services (HHS), which oversees NIH, “has been directed to fund research on a few specific areas” regarding “chemical and surgical mutilation” of children and adults,” according to multiple reports.
In particular, the Trump administration wants to investigate “regret and detransition following social transition as well as chemical and surgical mutilation of children and adults” and “outcomes from children who have undergone social transition and/or chemical and surgical mutilation.”
The new directives to the biomedical agency were reportedly included in an email to several NIH directors from then-Acting NIH Director Matthew Memoli shortly after Trump took office.
“This is very important to the President and the Secretary (of HHS, Robert F. Kennedy Jr.),” Memoli wrote.
Unhappy about the Trump administration’s move to uncover the hidden, shadowy side of the burgeoning transgender industry, pro-transgender activists working within the medical research community were quick to criticize the move.
The term “chemical or surgical mutilation” was “deeply offensive,” said Harry Barbee, assistant professor at the Johns Hopkins Bloomberg School of Public Health.
“This terminology has no place in serious scientific or public health discourse,” Barbee complained. “The language has been historically used to stigmatize trans people. Even the phrase(s) ‘regret’ and ‘detransition’ can be weaponized.”
“What they’re looking for is a political answer not a scientific one,” Adrian Shanker, who served as deputy assistant secretary for health policy at HHS under President Biden, told NPR. “That should be an alarm for everyone who cares about the scientific integrity of the National Institutes of Health.”
While those who derive a living focusing on developing and expanding the transgender industry resent the implication that there might be a dark side to their efforts, more than ample evidence has surfaced in recent years to warrant the White House’s investigation on behalf of vulnerable Americans, especially children, who have shown to be highly susceptible to what has been called the “transgender contagion.”
Many oft-ignored detransitioners attest to the physical and mental harm of reinforcing gender confusion as well as to the bias and negligence of the medical establishment on the subject, many of whom take an activist approach to their profession and begin cases with a predetermined conclusion in favor of “transitioning.”
A study published earlier this year in the Oxford Journal of Sexual Medicine found that undergoing sex-change surgery, far from reducing depression rates among the gender dysphoric, substantially increased rates not only of depression but of anxiety, suicidal ideation, and substance use disorders.
This study, along with scores of others conducted in recent years, explodes the media-enforced narrative that so-called “gender affirming” medical treatments are necessary for the happiness and well-being of the gender-confused.
Short video displays deep regret after sex-change treatments and surgery
A short video – just 34 seconds long – displays the extreme distress and anxiety of those who resorted to surgery and hormone treatments to “transition” earlier in their lives, only to experience deep regret later on.
The video presents a cautionary tale, dispelling the myth that parents need to allow their children to transition in order to be happy.
“Society is marketing a horrifically harmful, fashionable new trend to children that brings about a life of depression, confusion, drug use and STD’s,” the caption reads. “Please inform yourselves and help your children.”
Former transgender: ‘Regret’ and ‘detransitioning’ are the new trans frontier
Walt Heyer, a former “transgender woman” who for many years has maintained a global outreach to those who experience sex change regret, has been sounding the alarm about the one-size-fits-all approach of the trans medical industry for years.
“The science of surgical interventions is not yet settled regarding the long-term consequences of transgender therapy,” Heyer noted during a 2017 Symposium at the University of Hong Kong. “As of today, we don’t have any objective, conclusive research.”
“I feel ‘regret’ and ‘detransitioning’ will become the next transgender frontier,” Heyer said. “So be prepared.”
“There is an ever-increasing number of former transgenders, like myself, who are now requesting gender reversals,” he said.
“As a former female transgender, I can see the exploding social trend that has developed into a significant transgender contagion —now even an epidemic— that has captivated young children as well as young adults who have come to believe they’re the opposite sex on just the weight of social media and feelings … in some cases taking drastic measures to change their bodies,” Heyer said.
“More and more, I get reports from families telling me that their teen children suddenly came out as a transgender without any prior history of discomfort with their biological sex,” said Heyer, describing what has come to be called “rapid onset gender dysphoria.”
“Current psychotherapeutic practice involves the immediate affirmation of the young person’s self-diagnosis,” he lamented.
Heyer explained that many surgically transformed men and women suffer from a complex number of sexual, emotional, psychiatric and psychological comorbid disorders such as autogynephilia, dissociative disorders like schizophrenia, body dysmorphic disorder, and a host of other undiagnosed disorders that were not resolved by the recommended therapy of changing genders.
Heyer spoke from his own experience as he explained that if such disorders were considered and treated adequately, sexual transitioning would probably be greatly reduced. The role of these “comorbid” conditions tends to surface later as trans individuals begin to question their decision to transition to the opposite sex.
“We find this out from the ‘regretters,’” Heyer said. “We don’t find it out early on. We find it out afterward when they’re seeking help … and we find out that these comorbid disorders existed early on.”
A significant body of evidence now shows that “affirming” gender confusion carries serious harms, especially when done with impressionable children who lack the mental development, emotional maturity, and life experience to consider the long-term ramifications of the decisions being pushed on them or full knowledge about the long-term effects of life-altering, physically transformative, and often irreversible surgical and chemical procedures.
Studies find that more than 80 percent of children suffering gender dysphoria outgrow it on their own by late adolescence, and that “transition” procedures fail to resolve gender-confused individuals’ heightened tendency to engage in self-harm and suicide – and even exacerbate it, including by reinforcing their confusion and neglecting the actual root causes of their mental strife.
-
2025 Federal Election2 days ago
ASK YOURSELF! – Can Canada Endure, or Afford the Economic Stagnation of Carney’s Costly Climate Vision?
-
Alberta2 days ago
Made in Alberta! Province makes it easier to support local products with Buy Local program
-
2025 Federal Election22 hours ago
Euthanasia is out of control in Canada, but nobody is talking about it on the campaign trail
-
2025 Federal Election9 hours ago
MEI-Ipsos poll: 56 per cent of Canadians support increasing access to non-governmental healthcare providers
-
2025 Federal Election17 hours ago
AI-Driven Election Interference from China, Russia, and Iran Expected, Canadian Security Officials Warn
-
2025 Federal Election2 days ago
CSIS Warned Beijing Would Brand Conservatives as Trumpian. Now Carney’s Campaign Is Doing It.
-
2025 Federal Election2 days ago
Inside Buttongate: How the Liberal Swamp Tried to Smear the Conservative Movement — and Got Exposed
-
illegal immigration1 day ago
Despite court rulings, the Trump Administration shows no interest in helping Abrego Garcia return to the U.S.